FindTrial
Sign In

To see effectivity and safety of anti seizure drugs in primary and secondary prevention of seizure in patients of Acute Encephalitis Syndrome.

Effectiveness and Safety of use of Antiseizure medications for the primary and secondary prophylaxis of seizures in Acute Encephalitis Syndrome in tertiary care hospital centre – A Prospective Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/076278
Enrollment
53
Registered
2024-11-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G040- Acute disseminated encephalitis and encephalomyelitis (ADEM)

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

All india institute of medical sciences, Raipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age more than 14 years Definite, probable or confirmed case of acute encephalitis syndrome as per WHO guidelines Patients prescribed antiseizure medications

Exclusion criteria

Exclusion criteria: Already taking ASM known case of epilepsy Undergone neurosurgical intervention With other presdisposing diseases

Design outcomes

Primary

MeasureTime frame
Proportion of patient having no clinical seizure till time of discharge after initiation of treatment. Timepoint: every week till the time of discharge and at the end of 3 months.—

Secondary

MeasureTime frame
Proportion of patients having improvement in EEG at the end of 3 months after initiation of treatment as compared to baseline.Timepoint: 3 months—

Countries

India

Contacts

Public ContactDr Riya

AIIMS, Raipur

drynkeche@aiimsraipur.edu.in8818882119

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026